Prescription Medicines
Limalpha Tab.
- Product Category
- Treatment for lumbar spinal stenosis and obliterative thromboangiitis
- Active Ingredients
- Lima Frost Alphadex 166.67㎍
- Appearance
- A white, round tablet.
- Reimbursement Code
- 648103230
01 / 02
1. Composition and Strength : 1 tablet
- Active ingredient: Lima Frost Alphadex (JP) ---------- 166.67㎍ (5㎍ as Lima Frost)
- Additives (animal-derived ingredients): Lactose hydrate (cow, milk)
- Other additives: Microcellac 100, maltodextrin, microcrystalline cellulose, stearic acid, corn starch, colloidal silicon oxide
2. Efficacy/Effectiveness
1. Improvement of ischemic symptoms such as ulcers, pain, and cold sensation caused by obliterative thromboangiitis (Buerger's disease)
2. Improvement of subjective symptoms (pain in lower extremities, numbness in lower extremities) and walking ability due to acquired lumbar spinal stenosis (patients with normal SLR test and bilateral intermittent claudication)
3. Usage/Dosage
1. To improve ischemic symptoms such as ulcers, pain, and coldness caused by thromboangiitis obliterans (Buerger's disease), adults are usually administered orally 3 times a day, 2 tablets at a time.
2. Improvement of subjective symptoms (pain in lower extremities, numbness in lower extremities) and walking ability due to acquired lumbar spinal stenosis (patients with normal SLR test and bilateral intermittent claudication)
Adults are usually administered orally 3 times a day, 1 tablet per time.
Increase or decrease appropriately depending on age and symptoms.
4. Precautions for use
1. Do not administer to the following patients.
1) Pregnant woman or woman who may be pregnant
2) Since this drug contains lactose, it should not be administered to patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.
2. Administer with caution to the following patients.
1) Patients with bleeding tendencies (there is a risk of encouraging bleeding)
2) Patients taking antiplatelet agents, thrombolytics, or anticoagulants
3. Adverse reactions
1) Hypersensitivity: Occasionally rash, itching, etc. may occur, so in such cases, take appropriate measures such as discontinuing administration.
2) Bleeding tendency: In rare cases, bleeding may occur, so observe thoroughly and discontinue administration if any abnormalities are observed.
3) Digestive system: Occasionally diarrhea, nausea, abdominal discomfort, abdominal pain, loss of appetite, heartburn, and rarely vomiting and abdominal bloating may occur.
4) Liver: Occasionally liver function abnormalities such as increased AST (GOT) and ALT (GPT) may occur.
5) Circulatory system: Sometimes palpitations, rarely extremity cyanosis, and low blood pressure may occur.
6) Others: Occasionally, headache, facial flushing, dizziness, hot flashes, rare body malaise, edema, mammary gland swelling, body tremors, hair on the lower extremities, and anemia may occur.
4. General precautions
1) For lumbar spinal stenosis, observe the progress of symptoms and decide whether to continue administration.
2) Effectiveness in severe cases of lumbar spinal stenosis requiring surgery has not been established.
5. Administration to pregnant women
1) Since the safety of administration during pregnancy has not been established, it should not be administered to pregnant women or women who may be pregnant.
2) Uterine contraction effect has been reported in animal experiments (intravenous injection into pregnant monkeys and rats).
6. Administration to children
Safety for children has not been established (there is no experience with use).
7. Administration to elderly people
In general, elderly people have reduced physiological function, so they should be careful about reducing their intake.
8. Other
There are reports that a temporary drop in blood pressure occurred when administered in large quantities (30 to 40 μg/time) to healthy adults.
5. How to save
Airtight container, stored at room temperature (1~30℃)
6. Packaging unit
84 tablets (21 tablets/Alu-Alu
7. Expiration date
36 months from date of manufacture
- Active ingredient: Lima Frost Alphadex (JP) ---------- 166.67㎍ (5㎍ as Lima Frost)
- Additives (animal-derived ingredients): Lactose hydrate (cow, milk)
- Other additives: Microcellac 100, maltodextrin, microcrystalline cellulose, stearic acid, corn starch, colloidal silicon oxide
2. Efficacy/Effectiveness
1. Improvement of ischemic symptoms such as ulcers, pain, and cold sensation caused by obliterative thromboangiitis (Buerger's disease)
2. Improvement of subjective symptoms (pain in lower extremities, numbness in lower extremities) and walking ability due to acquired lumbar spinal stenosis (patients with normal SLR test and bilateral intermittent claudication)
3. Usage/Dosage
1. To improve ischemic symptoms such as ulcers, pain, and coldness caused by thromboangiitis obliterans (Buerger's disease), adults are usually administered orally 3 times a day, 2 tablets at a time.
2. Improvement of subjective symptoms (pain in lower extremities, numbness in lower extremities) and walking ability due to acquired lumbar spinal stenosis (patients with normal SLR test and bilateral intermittent claudication)
Adults are usually administered orally 3 times a day, 1 tablet per time.
Increase or decrease appropriately depending on age and symptoms.
4. Precautions for use
1. Do not administer to the following patients.
1) Pregnant woman or woman who may be pregnant
2) Since this drug contains lactose, it should not be administered to patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.
2. Administer with caution to the following patients.
1) Patients with bleeding tendencies (there is a risk of encouraging bleeding)
2) Patients taking antiplatelet agents, thrombolytics, or anticoagulants
3. Adverse reactions
1) Hypersensitivity: Occasionally rash, itching, etc. may occur, so in such cases, take appropriate measures such as discontinuing administration.
2) Bleeding tendency: In rare cases, bleeding may occur, so observe thoroughly and discontinue administration if any abnormalities are observed.
3) Digestive system: Occasionally diarrhea, nausea, abdominal discomfort, abdominal pain, loss of appetite, heartburn, and rarely vomiting and abdominal bloating may occur.
4) Liver: Occasionally liver function abnormalities such as increased AST (GOT) and ALT (GPT) may occur.
5) Circulatory system: Sometimes palpitations, rarely extremity cyanosis, and low blood pressure may occur.
6) Others: Occasionally, headache, facial flushing, dizziness, hot flashes, rare body malaise, edema, mammary gland swelling, body tremors, hair on the lower extremities, and anemia may occur.
4. General precautions
1) For lumbar spinal stenosis, observe the progress of symptoms and decide whether to continue administration.
2) Effectiveness in severe cases of lumbar spinal stenosis requiring surgery has not been established.
5. Administration to pregnant women
1) Since the safety of administration during pregnancy has not been established, it should not be administered to pregnant women or women who may be pregnant.
2) Uterine contraction effect has been reported in animal experiments (intravenous injection into pregnant monkeys and rats).
6. Administration to children
Safety for children has not been established (there is no experience with use).
7. Administration to elderly people
In general, elderly people have reduced physiological function, so they should be careful about reducing their intake.
8. Other
There are reports that a temporary drop in blood pressure occurred when administered in large quantities (30 to 40 μg/time) to healthy adults.
5. How to save
Airtight container, stored at room temperature (1~30℃)
6. Packaging unit
84 tablets (21 tablets/Alu-Alu
7. Expiration date
36 months from date of manufacture